What is EVOK's gross margin?

Evoke Pharma (EVOK) has a gross margin of 98% and a net margin of -27%.

What is EVOK's P/E ratio?

Track Evoke Pharma (EVOK) P/E ratio, ROE, and valuation metrics over time.

Where can I see EVOK's full financials?

See Evoke Pharma (EVOK) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Evoke Pharma (EVOK) Financials — Revenue, Earnings, Cash Flow

$11.00

Last traded 2025-12-16 — delisted

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $18.9M mcap · 1M float · 7.17% daily turnover · Short 35% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$14M

Revenue

+67.4% YoY

$-5M

Net Income

+15.0% YoY

$-3M

Free Cash Flow

+37.6% YoY

97.6%

Gross Margin

-26.6%

Op. Margin

-27.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-134.9%

ROA-35.1%

ROIC132.3%

Valuation

P/E-10.3

P/B8.4

EV/EBITDA-1.3

Leverage

Debt/Equity1.52

Current Ratio1.27

Interest Cov.-9.5x

Quality Scores

Piotroski F5/9

Altman Z-11.08

Beneish M-2.86